ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
AstraZeneca
National Institutes of Health Clinical Center (CC)
Servier
Myeloid Therapeutics
DualityBio Inc.
NextCure, Inc.
Tanabe Pharma America, Inc.
Eli Lilly and Company
Yuhan Corporation
Marengo Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Evopoint Biosciences Inc.
University of Colorado, Denver
Zumutor Biologics Inc.
Taiho Pharmaceutical Co., Ltd.